Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-034369
Filing Date
2019-06-04
Accepted
2019-06-04 16:55:08
Documents
1
Period of Report
2019-06-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3912
  Complete submission text file 0001209191-19-034369.txt   5224
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Issuer) CIK: 0001755237 (see all company filings)

EIN.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CYCLERION THERAPEUTICS CAMBRIDGE MA 02142
Business Address
Churchwell Kevin (Reporting) CIK: 0001771984 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38787 | Film No.: 19877342